Ocular insert apparatus and methods

• US 8,715,712 B2
• Filed: 11/28/2012
• Issued: 05/06/2014
• Est. Priority Date: 09/14/2011
• Status: Active Grant

• Current Assignee: ForSight VISION5, Inc. (Abbvie Incorporated)
• Original Assignee: ForSight VISION5, Inc. (Abbvie Incorporated)
• Inventors: de Juan, Eugene Jr., Alster, Yair, Reich, Cary J., MacFarlane, K. Angela, Chang, Janelle, Alejandro, Jose D.
• Primary Examiner(s): PACKARD, BENJAMIN J
• Application Number:
  US13/688,019
• Publication Number:
  US 20130090612A1
• Time in Patent Office: 524 Days
• Field of Search: 424/427
• US Class Current: 424/427
• CPC Class Codes: A61B 17/00234 for minimally invasive surgery A61B17/0218, A61B17/0469, A61B17/12013, A61B17/1285, A61B17/29, A61B17/320016 take precedence
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61K 47/34 Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers A61K47/10 takes precedence
• CPC Class Codes: A61K 9/0051 Ocular inserts, ocular implants
• CPC Class Codes: A61L 27/025 Other specific inorganic materials not covered by A61L27/04 - A61L27/12
• CPC Class Codes: A61L 27/16 obtained by reactions only involving carbon-to-carbon unsaturated bonds
• CPC Class Codes: A61P 27/02 Ophthalmic agents

Abstract

A comfortable insert comprises a retention structure sized for placement under the eyelids and along at least a portion of conjunctival sac of the upper and lower lids of the eye. The retention structure resists deflection when placed in the conjunctival sac of the eye and to guide the insert along the sac when the eye moves. The retention structure can be configured in many ways to provide the resistance to deflection and may comprise a hoop strength so as to urge the retention structure outward and inhibit movement of the retention structure toward the cornea. The insert may move rotationally with deflection along the conjunctival sac, and may comprise a retention structure having a cross sectional dimension sized to fit within folds of the conjunctiva. The insert may comprise a release mechanism and therapeutic agent to release therapeutic amounts of the therapeutic agent for an extended time.

Claims

1. An ocular insert for delivering at least one therapeutic agent to an eye for an extended period of time, the insert comprising:

a first structure configured to be positioned on the eye outside a cornea of the eye and at least partially underneath at least one of the upper and lower eyelids, wherein the first structure provides a first shape of the ocular insert;

a second structure supported by the first structure, wherein the second structure is of a different hardness than a material of the first structure; and

at least one therapeutic agent coupled to the ocular insert;

wherein the ocular insert has a first shape prior to being positioned onto the eye, and the ocular insert conforms in situ to a second shape upon being positioned onto the eye for a period of time, and wherein, after being removed from the eye, the ocular insert retains a shape that is different from the first shape.

2. An ocular insert as in claim 1, wherein the second shape conforms to a shape of the eye.

3. An ocular insert as in claim 1, wherein the second shape conforms at least in part to an anterior surface of the eye.

4. An ocular insert as in claim 1, wherein the second shape conforms at least in part to an anterior surface of the eye outside of the cornea.

5. An ocular insert as in claim 1, wherein the second shape conforms at least in part to a region of a formix of the eye.

6. An ocular insert as in claim 1, wherein the second shape conforms at least in part to a shape of the bony orbit of the eye.

7. An ocular insert as in claim 1, wherein the ocular insert resists deflection away from the removed shape upon being removed from the eye.

8. An ocular insert as in claim 1, wherein the first shape is annular.

9. An ocular insert as in claim 1, wherein the first shape is positioned substantially within a first plane and the removed shape at least partially extends outside of the first plane.

10. An ocular insert as in claim 1, wherein the therapeutic agent is coupled to the first structure.

11. An ocular insert as in claim 1, wherein the therapeutic agent is coupled to the second structure.

12. An ocular insert as in claim 1, wherein the first structure comprises polypropylene.

13. An ocular insert as in claim 1, wherein the second structure comprises a silicone material.

14. An ocular insert as in claim 1, wherein the silicone material comprises the at least one therapeutic agent.

15. An ocular insert as in claim 1, wherein the second structure comprises the at least one therapeutic agent.

16. An ocular insert as in claim 1, wherein the at least one therapeutic agent comprises a prostaglandin analogue.

17. An ocular insert as in claim 16, wherein the prostaglandin analogue comprises at least one of bimatoprost, latanoprost, travoprost, and tafluprost.

18. An ocular insert as in claim 1, wherein the at least one therapeutic agent is for lowering the intraocular pressure of the eye.

19. An ocular insert as in claim 1, wherein the insert comprises one or more haptics for assisting positioning the insert on the eye.

20. An ocular insert as in claim 1, wherein the first structure is annular.

21. An ocular insert as in claim 1, wherein the first structure is a portion of a ring.

22. An ocular insert as in claim 1, wherein the period of time the ocular insert is positioned on the eye is a day.

23. An ocular insert as in claim 1, wherein the first structure is configured to be positioned onto an anterior surface of the eye.

24. An ocular insert as in claim 1, wherein the second structure is formed of a different material than the first structure.

25. An ocular insert as in claim 1, wherein the second structure is formed of the same material as the first structure.